CLEARPOINT NEURO INC. - COMMON STOCK
5.8300
13-مايو-24 09:18:23
15 متأخرة بدقائق
الأسهم
-0.0300
-0.51%
نطاق اليوم
5.8300 - 6.0700
ISIN
N/A
المصدر
NASDAQ
-
ClearPoint Neuro Reports First Quarter 2024 Results
07 مايو 2024 15:05:00 بحسب Nasdaq GlobeNewswire
-
02 مايو 2024 15:05:00 بحسب Nasdaq GlobeNewswire
-
ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor Accessory
29 أبريل 2024 07:00:00 بحسب Nasdaq GlobeNewswire
-
24 أبريل 2024 15:05:00 بحسب Nasdaq GlobeNewswire
-
ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024
23 أبريل 2024 15:05:00 بحسب Nasdaq GlobeNewswire
-
16 أبريل 2024 15:05:00 بحسب Nasdaq GlobeNewswire
-
19 مارس 2024 07:07:06 بحسب Nasdaq GlobeNewswire
-
ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results
12 مارس 2024 15:05:00 بحسب Nasdaq GlobeNewswire
-
11 مارس 2024 07:00:00 بحسب Nasdaq GlobeNewswire
-
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024
01 مارس 2024 15:05:00 بحسب Nasdaq GlobeNewswire
-
ClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common Stock
29 فبراير 2024 07:00:00 بحسب Nasdaq GlobeNewswire
-
ClearPoint Neuro Launches Proposed Public Offering of Common Stock
28 فبراير 2024 15:45:35 بحسب Nasdaq GlobeNewswire
-
21 فبراير 2024 15:05:00 بحسب Nasdaq GlobeNewswire
-
24 يناير 2024 15:05:00 بحسب Nasdaq GlobeNewswire
-
ClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to Europe
22 يناير 2024 15:05:00 بحسب Nasdaq GlobeNewswire
-
ClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic System
16 يناير 2024 07:00:00 بحسب Nasdaq GlobeNewswire
-
08 يناير 2024 15:05:00 بحسب Nasdaq GlobeNewswire
-
ClearPoint Neuro Reports Third Quarter 2023 Results
09 نوفمبر 2023 15:05:01 بحسب Nasdaq GlobeNewswire
-
ClearPoint Neuro to Announce Third Quarter 2023 Results November 9, 2023
26 أكتوبر 2023 15:05:00 بحسب Nasdaq GlobeNewswire
-
ClearPoint Neuro Reports Second Quarter 2023 Results
08 أغسطس 2023 15:05:01 بحسب Nasdaq GlobeNewswire
- <<
- <
- 1
- >